Adage Capital’s Top Q3 Healthcare Sector Stock Holdings

Following is information regarding Adage Capital Partners’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011:

  • Pfizer, Inc. (NYSE:PFE): On 6/30/11 Adage Capital Partners reported holding 14,453,827 shares with a market value of $297,748,842. This comprised 1.13% of the total portfolio. On 9/30/11, Adage Capital Partners held 14,600,927 shares with a market value of $258,144,394. This comprised 1.23% of the total portfolio. The net change in shares for this position over the two quarters is 147,100. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johsnon & Johnson (NYSE:JNJ): On 6/30/11 Adage Capital Partners reported holding 4,726,645 shares with a market value of $314,416,410. This comprised 1.19% of the total portfolio. On 9/30/11, Adage Capital Partners held 3,699,854 shares with a market value of $235,643,696. This comprised 1.12% of the total portfolio. The net change in shares for this position over the two quarters is -1,026,791. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Procter & Gamble Co. (NYSE:PG): On 6/30/11 Adage Capital Partners reported holding 3,106,947 shares with a market value of $197,508,620. This comprised 0.75% of the total portfolio. On 9/30/11, Adage Capital Partners held 2,556,447 shares with a market value of $161,516,322. This comprised 0.77% of the total portfolio. The net change in shares for this position over the two quarters is -550,500. About the company: The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Proctor & Gamble’s products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
  • Gilead Sciences, Inc. (NASDAQ:GILD): On 6/30/11 Adage Capital Partners reported holding 4,791,351 shares with a market value of $198,409,844. This comprised 0.75% of the total portfolio. On 9/30/11, Adage Capital Partners held 3,956,451 shares with a market value of $153,510,296. This comprised 0.73% of the total portfolio. The net change in shares for this position over the two quarters is -834,900. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Cephalon, Inc. (NASDAQ:CEPH): On 6/30/11 Adage Capital Partners reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 9/30/11, Adage Capital Partners held 1,576,829 shares with a market value of $127,250,095. This comprised 0.61% of the total portfolio. The net change in shares for this position over the two quarters is 1,576,829. About the company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.
  • Celanese Corp. (NYSE:CE): On 6/30/11 Adage Capital Partners reported holding 3,957,167 shares with a market value of $210,956,578. This comprised 0.80% of the total portfolio. On 9/30/11, Adage Capital Partners held 3,849,089 shares with a market value of $125,210,860. This comprised 0.60% of the total portfolio. The net change in shares for this position over the two quarters is -108,078. About the company: Celanese Corporation is a global industrial chemicals company. Its business involves processing chemical raw materials, such as ethylene and propylene, and natural products, including natural gas and wood pulp, into chemicals and chemical-based products.
  • Merck & Co., Inc. (NYSE:MRK): On 6/30/11 Adage Capital Partners reported holding 3,942,678 shares with a market value of $139,137,110. This comprised 0.53% of the total portfolio. On 9/30/11, Adage Capital Partners held 3,703,278 shares with a market value of $121,097,193. This comprised 0.58% of the total portfolio. The net change in shares for this position over the two quarters is -239,400. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Baxter International, Inc. (NYSE:BAX): On 6/30/11 Adage Capital Partners reported holding 2,333,398 shares with a market value of $139,280,523. This comprised 0.53% of the total portfolio. On 9/30/11, Adage Capital Partners held 2,021,983 shares with a market value of $113,514,124. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is -311,415. About the company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Bristol-Myers Squibb Co. (NYSE:BMY): On 6/30/11 Adage Capital Partners reported holding 3,626,358 shares with a market value of $105,019,324. This comprised 0.40% of the total portfolio. On 9/30/11, Adage Capital Partners held 3,349,158 shares with a market value of $105,096,575. This comprised 0.50% of the total portfolio. The net change in shares for this position over the two quarters is -277,200. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Covidien plc (NYSE:COV): On 6/30/11 Adage Capital Partners reported holding 2,027,900 shares with a market value of $107,945,116. This comprised 0.41% of the total portfolio. On 9/30/11, Adage Capital Partners held 2,097,600 shares with a market value of $92,504,157. This comprised 0.44% of the total portfolio. The net change in shares for this position over the two quarters is 69,700. About the company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

(Note: Data regarding Adage Capital Partners’ stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet